This week on Contemporary OB/GYN®: September 6 to September 10
Expect a variety of topics to be covered this week.
Here's what to look forward to this week:
Updated statement on managing osteoporosis in postmenopause
Successfully managing osteoporosis in postmenopausal women revolves around risk factors and risk-assessment tools for identifying women who are candidates for pharmacologic therapy, according to an updated position statement from the North American Menopause Society (NAMS).
Getting started with office hysteroscopy
Despite advantages to its use, the procedure remains underutilized. Two experts outline an approach for getting started.
PFAS in drinking water and its impact on the female reproductive system
A Swedish cohort study in the journal Environment International has found that women of fertile age who were exposed to high levels of perfluorinated substances (PFAS) in drinking water were significantly more likely to subsequently have a diagnosis of polycystic ovarian syndrome (PCOS) and possibly uterine leiomyoma (or uterine fibroids [UFs]), but not endometriosis.
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More
Hyperoxygenation use not linked to neonatal outcomes
April 23rd 2024Recent research evaluated the impact of maternal hyperoxygenation on neonatal Apgar scores, revealing no significant enhancement in outcomes among women with pathologic fetal heart rate tracing and suggesting limited efficacy of hyperoxygenation therapy in this context.
Read More
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More
